Altasciences and QPS, PE-backed pharma-service companies on the block

Altasciences, QPS, pharma service, private equity, merger, m&a
  • Companies support early-stage drug development
  • Fairmount advises Kilmer Capital’s Altasciences
  • Wells Fargo advises Argentum’s QPS
Altasciences Clinical Research and QPS Holdings, two private-equity-backed pharmaceutical-services companies focused on early-phase drug development, are exploring potential sales, according to sources. Wells Fargo has the mandate to sell Argentum Group’s QPS, three sources said. Two said Kilmer Capital Partners’ Altasciences is the midst of ...

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.

Digital Edition


To read a digital copy of our latest magazine

click here

PE News Briefs